Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Diabetes

  Free Subscription


15.02.2021

1 Ann Intern Med
5 Biochem Biophys Res Commun
5 BMC Ophthalmol
1 Circulation
7 Diabet Med
2 Diabetes
13 Diabetes Care
4 Diabetes Obes Metab
4 Diabetologia
1 Eur J Endocrinol
1 J Am Soc Nephrol
10 J Clin Endocrinol Metab
7 J Diabetes Complications
1 J Hypertens
1 Nat Genet
1 Nutr Metab (Lond)
9 PLoS One
1 Proc Natl Acad Sci U S A
1 Retina
4 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. KIM NH, Siddiqui M, Vogel J
    MELAS Syndrome and MIDD Unmasked by Metformin Use: A Case Report.
    Ann Intern Med. 2021;174:124-125.
    PubMed        


    Biochem Biophys Res Commun

  2. HONGBO M, Yanjiao D, Shuo W, Kun S, et al
    Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Biochem Biophys Res Commun. 2021;545:46-53.
    PubMed         Abstract available

  3. MIYATAKE Y, Mishima Y, Tsutsumi R, Otani T, et al
    Assessment of insulin resistance in the skeletal muscle of mice using positron emission tomography/computed tomography imaging.
    Biochem Biophys Res Commun. 2020;528:499-505.
    PubMed         Abstract available

  4. DIAO J, Zhao H, You P, You H, et al
    Rosmarinic acid ameliorated cardiac dysfunction and mitochondrial injury in diabetic cardiomyopathy mice via activation of the SIRT1/PGC-1alpha pathway.
    Biochem Biophys Res Commun. 2021;546:29-34.
    PubMed         Abstract available

  5. YUN JH
    Interleukin-1beta induces pericyte apoptosis via the NF-kappaB pathway in diabetic retinopathy.
    Biochem Biophys Res Commun. 2021;546:46-53.
    PubMed         Abstract available

  6. SUJJITJOON J, Charoensuk C, Thanyaphon T, Kooptiwut S, et al
    Defective functions of HNF1A variants on BCL2L1 transactivation and beta-cell growth.
    Biochem Biophys Res Commun. 2020;529:826-833.
    PubMed         Abstract available


    BMC Ophthalmol

  7. YOSHIDA M, Yokokura S, Nishida T, Mochizuki K, et al
    Endogenous endophthalmitis caused by group B streptococcus; case reports and review of 35 reported cases.
    BMC Ophthalmol. 2020;20:126.
    PubMed         Abstract available

  8. PORTELA ALBM, Moreno RN, Ribeiro MHML, de Andrade FM, et al
    Role of nicergoline in corneal wound healing in diabetic rats.
    BMC Ophthalmol. 2021;21:77.
    PubMed         Abstract available

  9. VOLKMANN I, Knoll K, Wiezorrek M, Greb O, et al
    Individualized treat-and-extend regime for optimization of real-world vision outcome and improved patients' persistence.
    BMC Ophthalmol. 2020;20:122.
    PubMed         Abstract available

  10. ZHANG K, Zhao L, Zhu C, Nan W, et al
    The effect of diabetes on corneal endothelium: a meta-analysis.
    BMC Ophthalmol. 2021;21:78.
    PubMed         Abstract available

  11. BENJAMIN JE, Sun J, Cohen D, Matz J, et al
    A 15 month experience with a primary care-based telemedicine screening program for diabetic retinopathy.
    BMC Ophthalmol. 2021;21:70.
    PubMed         Abstract available


    Circulation

  12. YE N, Jardine MJ, Oshima M, Hockham C, et al
    Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights from the CREDENCE Trial.
    Circulation. 2021 Feb 8. doi: 10.1161/CIRCULATIONAHA.120.048740.
    PubMed         Abstract available


    Diabet Med

  13. STRACHAN M, Foteinopoulou E
    Response to Comment on "Impact of Routine Clinic Measurement of Random Serum C-peptide in People with a Clinician Diagnosis of Type 1 Diabetes" doi:10.1111/dme.14449.
    Diabet Med. 2021 Feb 5:e14537. doi: 10.1111/dme.14537.
    PubMed         Abstract available

  14. THOMAS RL, Cheung WY, Rafferty JM, Luzio SD, et al
    Characteristics of repeat non-attenders at Diabetes Eye Screening Wales, a national community-based diabetes related retinopathy screening service, during 2003 - 2018.
    Diabet Med. 2021 Feb 5:e14536. doi: 10.1111/dme.14536.
    PubMed         Abstract available

  15. HERNAR I, Graue M, Strandberg RB, Lie SS, et al
    Young adults with type 1 diabetes and their experiences with diabetes follow-up and participation in the DiaPROM pilot trial: a qualitative study.
    Diabet Med. 2021 Feb 5:e14535. doi: 10.1111/dme.14535.
    PubMed         Abstract available

  16. LIANG X, Etches J, Pinzaru B, Tu K, et al
    The quality of diabetes care among cancer survivors: a retrospective cohort study.
    Diabet Med. 2021 Feb 6:e14538. doi: 10.1111/dme.14538.
    PubMed         Abstract available

  17. SAUNDERS I, Bain SC
    A woman with poorly controlled type 1 diabetes and pruritic papules on her buttocks.
    Diabet Med. 2021 Feb 10:e14539. doi: 10.1111/dme.14539.
    PubMed         Abstract available

  18. PIERSE T, O'Neill S, Dinneen SF, O'Neill C, et al
    A simulation study of the economic and health impact of a diabetes prevention programme in Ireland.
    Diabet Med. 2021 Feb 11:e14540. doi: 10.1111/dme.14540.
    PubMed         Abstract available

  19. ROBINSON ME, Simard M, Larocque I, Shah J, et al
    Psychiatric disorders in emerging adults with diabetes transitioning to adult care: a retrospective cohort study.
    Diabet Med. 2021 Feb 12:e14541. doi: 10.1111/dme.14541.
    PubMed         Abstract available


    Diabetes

  20. CHEN WY, Han X, Cui LJ, Yu CX, et al
    Cell-Subtype-Specific Remodeling of Intrinsically Photosensitive Retinal Ganglion Cells in Streptozotocin-Induced Diabetic Mice.
    Diabetes. 2021 Feb 11. pii: db20-0775. doi: 10.2337/db20-0775.
    PubMed         Abstract available

  21. SACHSE G, Haythorne E, Hill T, Proks P, et al
    The KCNJ11-E23K Gene Variant Hastens Diabetes Progression by Impairing Glucose-Induced Insulin Secretion.
    Diabetes. 2021 Feb 10. pii: db20-0691. doi: 10.2337/db20-0691.
    PubMed         Abstract available


    Diabetes Care

  22. HE Y, Lakhani CM, Rasooly D, Manrai AK, et al
    Comparisons of Polyexposure, Polygenic, and Clinical Risk Scores in Risk Prediction of Type 2 Diabetes.
    Diabetes Care. 2021 Feb 9. pii: dc20-2049. doi: 10.2337/dc20-2049.
    PubMed         Abstract available

  23. RIDDLE MC, Philipson LH, Rich SS, Carlsson A, et al
    Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors' Expert Forum.
    Diabetes Care. 2020;43:3117-3128.
    PubMed         Abstract available

  24. JEYAM A, Colhoun H, McGurnaghan S, Blackbourn L, et al
    Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390-398.
    Diabetes Care. 2021 Feb 5. pii: dc21er04b. doi: 10.2337.
    PubMed        

  25. MOKHLESI B, Tjaden AH, Temple KA, Edelstein SL, et al
    Obstructive Sleep Apnea, Glucose Tolerance, and beta-Cell Function in Adults With Prediabetes or Untreated Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study.
    Diabetes Care. 2021 Feb 5. pii: dc20-2127. doi: 10.2337/dc20-2127.
    PubMed         Abstract available

  26. NOH Y, Oh IS, Jeong HE, Filion KB, et al
    Association Between DPP-4 Inhibitors and COVID-19 Related Outcomes Among Patients With Type 2 Diabetes.
    Diabetes Care. 2021 Feb 5. pii: dc20-1824. doi: 10.2337/dc20-1824.
    PubMed        

  27. LING S, Zaccardi F, Lawson C, Seidu SI, et al
    Glucose Control, Sulfonylureas, and Insulin Treatment in Elderly People With Type 2 Diabetes and Risk of Severe Hypoglycemia and Death: An Observational Study.
    Diabetes Care. 2021 Feb 4. pii: dc20-0876. doi: 10.2337/dc20-0876.
    PubMed         Abstract available

  28. AGUILAR-RAMIREZ D, Alegre-Diaz J, Gnatiuc L, Ramirez-Reyes R, et al
    Changes in the Diagnosis and Management of Diabetes in Mexico City Between 1998-2004 and 2015-2019.
    Diabetes Care. 2021 Feb 10. pii: dc20-2276. doi: 10.2337/dc20-2276.
    PubMed         Abstract available

  29. CAMPBELL JA, Williams JS, Egede LE
    Examining the Relationship Between Delay Discounting, Delay Aversion, Diabetes Self-care Behaviors, and Diabetes Outcomes in U.S. Adults With Type 2 Diabetes.
    Diabetes Care. 2021 Feb 10. pii: dc20-2620. doi: 10.2337/dc20-2620.
    PubMed         Abstract available

  30. SHEN Y, Fan X, Zhang L, Wang Y, et al
    Thresholds of Glycemia and the Outcomes of COVID-19 Complicated With Diabetes: A Retrospective Exploratory Study Using Continuous Glucose Monitoring.
    Diabetes Care. 2021 Feb 11. pii: dc20-1448. doi: 10.2337/dc20-1448.
    PubMed         Abstract available

  31. DUBOURG J, Fouqueray P, Thang C, Grouin JM, et al
    Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial.
    Diabetes Care. 2021 Feb 11. pii: dc20-0763. doi: 10.2337/dc20-0763.
    PubMed         Abstract available

  32. RIDDLE MC, Bakris G, Blonde L, Boulton AJM, et al
    A Lesson From 2020: Public Health Matters for Both COVID-19 and Diabetes.
    Diabetes Care. 2021;44:8-10.
    PubMed        

  33. OGUNWOLE SM, Golden SH
    Social Determinants of Health and Structural Inequities-Root Causes of Diabetes Disparities.
    Diabetes Care. 2021;44:11-13.
    PubMed        

  34. MAURAS N, Buckingham B, White NH, Tsalikian E, et al
    Impact of Type 1 Diabetes in the Developing Brain in Children: A Longitudinal Study.
    Diabetes Care. 2021 Feb 10. pii: dc20-2125. doi: 10.2337/dc20-2125.
    PubMed         Abstract available


    Diabetes Obes Metab

  35. MCKAY AJ, Gunn LH, Nugawela M, Sathish T, et al
    Associations between attainment of incentivised primary care indicators and incident sight-threatening diabetic retinopathy in the United Kingdom: A population-based historical cohort study.
    Diabetes Obes Metab. 2021 Feb 10. doi: 10.1111/dom.14344.
    PubMed         Abstract available

  36. ROSENSTOCK J, Blonde L, Aroda VR, Frias J, et al
    Switching to iGlarLixi vs Continuation of Daily or Weekly GLP-1 RA in Insufficiently Controlled Type 2 Diabetes: A LixiLan-G Trial Subgroup Analysis by HbA1c and GLP-1 RA Use at Screening.
    Diabetes Obes Metab. 2021 Feb 10. doi: 10.1111/dom.14345.
    PubMed         Abstract available

  37. AHMAD E, Waller HL, Sargeant JA, Webb MA, et al
    Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial.
    Diabetes Obes Metab. 2021 Feb 10. doi: 10.1111/dom.14343.
    PubMed         Abstract available

  38. SEINO Y, Kaku K, Kadowaki T, Okamoto T, et al
    A Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Sitagliptin in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control on Ipragliflozin.
    Diabetes Obes Metab. 2021 Feb 10. doi: 10.1111/dom.14346.
    PubMed         Abstract available


    Diabetologia

  39. BIESSELS GJ, Verhagen C, Janssen J, van den Berg E, et al
    Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study.
    Diabetologia. 2021 Feb 9. pii: 10.1007/s00125-021-05393.
    PubMed         Abstract available

  40. LINDELL N, Bladh M, Carlsson A, Josefsson A, et al
    Size for gestational age affects the risk for type 1 diabetes in children and adolescents: a Swedish national case-control study.
    Diabetologia. 2021 Feb 5. pii: 10.1007/s00125-021-05381.
    PubMed         Abstract available

  41. DRUCKER DJ
    Transforming type 1 diabetes: the next wave of innovation.
    Diabetologia. 2021 Feb 6. pii: 10.1007/s00125-021-05396.
    PubMed         Abstract available

  42. TORNOVSKY-BABEAY S, Weinberg-Corem N, Ben-Haroush Schyr R, Avrahami D, et al
    Biphasic dynamics of beta cell mass in a mouse model of congenital hyperinsulinism: implications for type 2 diabetes.
    Diabetologia. 2021 Feb 9. pii: 10.1007/s00125-021-05390.
    PubMed         Abstract available


    Eur J Endocrinol

  43. DEVUYST F, Kazakou P, Baleriaux D, Alexopoulou O, et al
    Pituitary stalk thickening: neoplastic or not? - author's response to the letter by Wang et al.
    Eur J Endocrinol. 2020;183:L23-L25.
    PubMed        


    J Am Soc Nephrol

  44. TUOT DS
    Improving Equity in Medication Use through Better Kidney Function Measurement.
    J Am Soc Nephrol. 2020;31:1657-1658.
    PubMed        


    J Clin Endocrinol Metab

  45. WANG B, Li M, Zhao Z, Wang S, et al
    Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals.
    J Clin Endocrinol Metab. 2020;105.
    PubMed         Abstract available

  46. ALVES JM, Zink J, Chow T, Luo S, et al
    Contributions of Prenatal Exposures and Child Lifestyle to Insulin Sensitivity.
    J Clin Endocrinol Metab. 2020;105.
    PubMed         Abstract available

  47. NG JCM, Schooling CM
    Effect of glucagon on ischemic heart disease and its risk factors: A Mendelian randomization study.
    J Clin Endocrinol Metab. 2020 May 14. pii: 5837127. doi: 10.1210.
    PubMed         Abstract available

  48. EBERT A, Konig J, Frommer L, Schuppan D, et al
    Chromogranin Serves as Novel Biomarker of Endocrine and Gastric Autoimmunity.
    J Clin Endocrinol Metab. 2020 May 21. pii: 5841628. doi: 10.1210.
    PubMed         Abstract available

  49. SOKOOTI S, Flores-Guerrero JL, Kieneker LM, Heerspink HJL, et al
    HDL particle subspecies and their association with incident type 2 diabetes: the PREVEND study.
    J Clin Endocrinol Metab. 2021 Feb 10. pii: 6132446. doi: 10.1210.
    PubMed         Abstract available

  50. WATANABE H, Takahara M, Katakami N, Shimomura I, et al
    Letter to the Editor from Watanabe: "Long-term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study".
    J Clin Endocrinol Metab. 2021 Feb 10. pii: 6131976. doi: 10.1210.
    PubMed        

  51. WANG J, Cooper JM, Gokhale K, Acosta-Mena D, et al
    Association of metformin with susceptibility to COVID-19 in people with Type 2 diabetes.
    J Clin Endocrinol Metab. 2021 Feb 9. pii: 6131731. doi: 10.1210.
    PubMed         Abstract available

  52. WINTHER SA, Rossing P
    TMAO: Trimethylamine-N-Oxide or Time to Minimize Intake of Animal Products?
    J Clin Endocrinol Metab. 2020;105.
    PubMed        

  53. PRESTON EV, Rifas-Shiman SL, Hivert MF, Zota AR, et al
    Associations of per- and polyfluoroalkyl substances (PFAS) with glucose tolerance during pregnancy in Project Viva.
    J Clin Endocrinol Metab. 2020 Jun 1. pii: 5849987. doi: 10.1210.
    PubMed         Abstract available

  54. KOZAKOVA M, Morizzo C, Penno G, Shore AC, et al
    Plasma Homocysteine and Cardiovascular Organ Damage in a Population with a High Prevalence of Risk Factors.
    J Clin Endocrinol Metab. 2020 May 26. pii: 5846189. doi: 10.1210.
    PubMed         Abstract available


    J Diabetes Complications

  55. GADSBY R
    Operationalising individualised glycaemic targets in older people with diabetes.
    J Diabetes Complications. 2021 Jan 28:107872.
    PubMed        

  56. GAINES H, Jones KR, Lim J, Medhi NF, et al
    Effect of CFTR modulator therapy on cystic fibrosis-related diabetes.
    J Diabetes Complications. 2021 Jan 5:107845. doi: 10.1016/j.jdiacomp.2020.107845
    PubMed         Abstract available

  57. TENG F, Qin R, Liu X, Geng H, et al
    Interaction between the rs9356744 polymorphism and metabolic risk factors in relation to type 2 diabetes mellitus: The Cardiometabolic Risk in Chinese (CRC) Study.
    J Diabetes Complications. 2021 Jan 29:107855.
    PubMed         Abstract available

  58. LEITE NC, Cardoso CRL, Salles GF
    Importance of non-invasive liver fibrosis scores for mortality and complications development in individuals with type 2 diabetes.
    J Diabetes Complications. 2021 Feb 2:107879. doi: 10.1016/j.jdiacomp.2021.107879
    PubMed         Abstract available

  59. MADSEN KP, Willaing I, Rod NH, Varga TV, et al
    Psychosocial health in people with diabetes during the first three months of the COVID-19 pandemic in Denmark.
    J Diabetes Complications. 2021 Jan 20:107858.
    PubMed         Abstract available

  60. ISHIZU M, Mori H, Ohishi M, Kuroda A, et al
    Urinary adiponectin excretion is an early predictive marker of the decline of the renal function in patients with diabetes mellitus.
    J Diabetes Complications. 2021 Jan 7:107848. doi: 10.1016/j.jdiacomp.2021.107848
    PubMed         Abstract available

  61. WITTBRODT E, Bhalla N, Sundell KA, Hunt P, et al
    Assessment of The High risk and unmEt Need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource use, cost, and burden of illness in a commercially insured population.
    J Diabetes Complications. 2021 Jan 20:107859.
    PubMed         Abstract available


    J Hypertens

  62. BOHM M, Schumacher H, Teo KK, Lonn EM, et al
    Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk.
    J Hypertens. 2021 Feb 3. pii: 00004872-900000000-96717.
    PubMed         Abstract available


    Nat Genet

  63. LOTTA LA, Pietzner M, Stewart ID, Wittemans LBL, et al
    A cross-platform approach identifies genetic regulators of human metabolism and health.
    Nat Genet. 2021;53:54-64.
    PubMed         Abstract available


    Nutr Metab (Lond)

  64. WANG H, Chen L, Shen D, Cao Y, et al
    Association of daytime napping in relation to risk of diabetes: evidence from a prospective study in Zhejiang, China.
    Nutr Metab (Lond). 2021;18:18.
    PubMed         Abstract available


    PLoS One

  65. KUDO K, Inoue T, Sonoda N, Ogawa Y, et al
    Relationship between serum bilirubin levels, urinary biopyrrin levels, and retinopathy in patients with diabetes.
    PLoS One. 2021;16:e0243407.
    PubMed         Abstract available

  66. LINDER S, Abu-Omar K, Geidl W, Messing S, et al
    Physical inactivity in healthy, obese, and diabetic adults in Germany: An analysis of related socio-demographic variables.
    PLoS One. 2021;16:e0246634.
    PubMed         Abstract available

  67. ABATE TW, Dessie G, Workineh Y, Gedamu H, et al
    Non-adherence to self-care and associated factors among diabetes adult population in Ethiopian: A systemic review with meta-analysis.
    PLoS One. 2021;16:e0245862.
    PubMed         Abstract available

  68. NASIR BB, Buseir MS, Muhammed OS
    Knowledge, attitude and practice towards insulin self-administration and associated factors among diabetic patients at Zewditu Memorial Hospital, Ethiopia.
    PLoS One. 2021;16:e0246741.
    PubMed         Abstract available


  69. Retraction: Transdermal Delivery of Insulin by Amidated Pectin Hydrogel Matrix Patch in Streptozotocin-Induced Diabetic Rats: Effects on Some Selected Metabolic Parameters.
    PLoS One. 2021;16:e0247150.
    PubMed        

  70. DINAH C, Ghulakhszian A, Sim SY, Minocha A, et al
    Aflibercept for treatment-naive diabetic macula oedema in a multi-ethnic population: Real-world outcomes from North West London.
    PLoS One. 2021;16:e0246626.
    PubMed         Abstract available

  71. ADENIYI O, Washington L, Glenn CJ, Franklin SG, et al
    The use of complementary and alternative medicine among hypertensive and type 2 diabetic patients in Western Jamaica: A mixed methods study.
    PLoS One. 2021;16:e0245163.
    PubMed         Abstract available

  72. PATIL P, Lalwani P, Vidwans H, Kulkarni S, et al
    A multidimensional functional fitness score has a stronger association with type 2 diabetes than obesity parameters in cross sectional data.
    PLoS One. 2021;16:e0245093.
    PubMed         Abstract available

  73. KIM J, Yoon SJ, Jo MW
    Estimating the disease burden of Korean type 2 diabetes mellitus patients considering its complications.
    PLoS One. 2021;16:e0246635.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  74. MITCHELL AM, Alkanani AA, McDaniel KA, Pyle L, et al
    T-cell responses to hybrid insulin peptides prior to type 1 diabetes development.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Retina

  75. IMAI H, Otsuka K, Tetsumoto A, Miki A, et al
    EFFECTIVENESS OF EN BLOC REMOVAL OF FIBRINOGEN-RICH COMPONENT OF CYSTOID LESION FOR THE TREATMENT OF CYSTOID MACULAR EDEMA.
    Retina. 2020;40:154-159.
    PubMed         Abstract available


    Transplantation

  76. LIM WH, Lok CE, Kim SJ, Knoll G, et al
    Impact of Pretransplant and New-Onset Diabetes After Transplantation on the Risk of Major Adverse Cardiovascular Events in Kidney Transplant Recipients: a Population-Based Cohort Study.
    Transplantation. 2021 Feb 4. pii: 00007890-900000000-95388.
    PubMed         Abstract available

  77. SAKATA N, Yoshimatsu G, Tanaka T, Yamada T, et al
    Mechanism of Transplanted Islet Engraftment in Visceral White Adipose Tissue.
    Transplantation. 2020;104:2516-2527.
    PubMed         Abstract available

  78. KUMANO K, Vasu S, Liu Y, Lo ST, et al
    Grafting Islets to a Dissected Peritoneal Pouch to Improve Transplant Survival and Function.
    Transplantation. 2020;104:2307-2316.
    PubMed         Abstract available

  79. YAO M, Watanabe M, Sun S, Tokodai K, et al
    Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand.
    Transplantation. 2020;104:2048-2058.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: